Betifisolimab

• Target :

  PD-1/PD-L1

• Related Pathways :

  Cell Cycle/Checkpoint|||Apoptosis|||Immunology/Inflammation

• Bioactivity :

  Betifisolimab (MSB-2311), a humanized monoclonal antibody targeting the immunosuppressive ligand PD-L1, shows promise for research in advanced solid tumors and hematological malignancies [1].

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2460539-60-8